TOT BIOPHARM International Company Limited

SEHK:1875 Stok Raporu

Piyasa değeri: HK$1.5b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

TOT BIOPHARM International Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

TOT BIOPHARM International has a total shareholder equity of CN¥723.9M and total debt of CN¥383.0M, which brings its debt-to-equity ratio to 52.9%. Its total assets and total liabilities are CN¥1.5B and CN¥732.8M respectively. TOT BIOPHARM International's EBIT is CN¥26.8M making its interest coverage ratio 9.2. It has cash and short-term investments of CN¥348.4M.

Anahtar bilgiler

52.9%

Borç/özkaynak oranı

CN¥383.01m

Borç

Faiz karşılama oranı9.2x
NakitCN¥348.35m
EşitlikCN¥723.89m
Toplam yükümlülüklerCN¥732.77m
Toplam varlıklarCN¥1.46b

Son finansal sağlık güncellemeleri

Recent updates

We Think Some Shareholders May Hesitate To Increase TOT BIOPHARM International Company Limited's (HKG:1875) CEO Compensation

Jun 07
We Think Some Shareholders May Hesitate To Increase TOT BIOPHARM International Company Limited's (HKG:1875) CEO Compensation

The Market Lifts TOT BIOPHARM International Company Limited (HKG:1875) Shares 29% But It Can Do More

May 21
The Market Lifts TOT BIOPHARM International Company Limited (HKG:1875) Shares 29% But It Can Do More

Is TOT BIOPHARM International (HKG:1875) Using Debt In A Risky Way?

Mar 18
Is TOT BIOPHARM International (HKG:1875) Using Debt In A Risky Way?

There's No Escaping TOT BIOPHARM International Company Limited's (HKG:1875) Muted Revenues

Dec 28
There's No Escaping TOT BIOPHARM International Company Limited's (HKG:1875) Muted Revenues

Does TOT BIOPHARM International (HKG:1875) Have A Healthy Balance Sheet?

Nov 23
Does TOT BIOPHARM International (HKG:1875) Have A Healthy Balance Sheet?

We Think TOT BIOPHARM International (HKG:1875) Has A Fair Chunk Of Debt

May 18
We Think TOT BIOPHARM International (HKG:1875) Has A Fair Chunk Of Debt

Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation

Jul 27
Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation

An Intrinsic Calculation For TOT BIOPHARM International Company Limited (HKG:1875) Suggests It's 41% Undervalued

Mar 26
An Intrinsic Calculation For TOT BIOPHARM International Company Limited (HKG:1875) Suggests It's 41% Undervalued

Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation

Feb 03
Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 1875's short term assets (CN¥720.3M) exceed its short term liabilities (CN¥372.0M).

Uzun Vadeli Yükümlülükler: 1875's short term assets (CN¥720.3M) exceed its long term liabilities (CN¥360.7M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 1875's net debt to equity ratio (4.8%) is considered satisfactory.

Borcun Azaltılması: 1875's debt to equity ratio has reduced from 126.3% to 52.9% over the past 5 years.

Borç Kapsamı: 1875 şirketinin borcu operating nakit flow ( 16.4% ) tarafından iyi karşılanmıyor.

Faiz Kapsamı: 1875's interest payments on its debt are well covered by EBIT (9.2x coverage).


Bilanço


Sağlıklı şirketleri keşfedin